Annual Drug Patent Expirations for ISENTRESS
Isentress is a drug marketed by Merck Sharp Dohme and is included in three NDAs. It is available from six suppliers. There are five patents protecting this drug and one Paragraph IV challenge.
The generic ingredient in ISENTRESS is raltegravir potassium. Six suppliers are listed for this compound. Additional details are available on the raltegravir potassium profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com